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identify surgical site infections (SSI) after breast surgery
and cesarean section. Postoperative diagnosis codes, pro-
cedure codes, and pharmacy information were automati-
cally scanned and used to identify claims suggestive of SSI
(“indicators”) among 426 (22%) of 1,943 breast procedures
and 474 (10%) of 4,859 cesarean sections. For 104 breast
procedures with indicators explained in available medical
records, SSI were confirmed for 37%, and some infection
criteria were present for another 27%. Among 204 cesare-
an sections, SSI were confirmed for 40%, and some crite-
ria were met for 27%. The extrapolated infection rates of
2.8% for breast procedures and 3.1% for cesarean section
were similar to those reported by the National Nosocomial
Infection Surveillance program but differ in representing
predominantly outpatient infections. Claims data may com-
plement other data sources for identification of surgical site
infections following breast surgery and caesarian section.
T
he most commonly used methods for surgical site
infection (SSI) surveillance are labor intensive, sus-
ceptible to variability, and relatively insensitive to SSI
after hospital discharge (1–17). Automated diagnosis and
treatment information created during routine healthcare
delivery, if sufficiently accurate, could be used to improve
SSI detection. Surveillance based on full-text electronic
medical records has outperformed more widely used meth-
ods (18,19), but currently these records exist for a minori-
ty of procedures. Diagnosis, procedure, and pharmacy
codes associated with insurance claims are widely avail-
able but provide less detailed information. Nevertheless,
claims data after coronary artery bypass grafting (CABG)
identified 45% more SSI than did traditional surveillance
(20). Claims data also allowed comparison of infection
rates between hospitals (21). We investigated the utility of
claims data after breast surgery and cesarean section for
infection surveillance; these procedures are among the
most commonly performed. Assessing different procedure
types is important because differences in the duration of
hospitalization, inpatient management, postdischarge care,
and practices in billing and reimbursement that underlie
claims data may vary substantially among different types
of procedures. 
Methods
Breast Surgery
Automated Data
The study population was drawn from three different
administrative claims systems within Harvard Pilgrim
Health Care from July 1997 through February 1999 and
one system of Tufts Health Plan from January 1996
through February 1999. All members had benefits that
would be expected to generate inpatient and outpatient
diagnosis and procedure claims; 90% of members also had
pharmacy benefits (unpub. data). Breast procedures were
identified by International Classification of Diseases 9th
Revision Clinical Modification (ICD-9-CM) or Current
Procedural Terminology (CPT) procedure codes (online
Appendix 1 available from http://www.cdc.gov/ncidod/
eid/vol10no11/04-0784_app1.htm). Breast surgeries were
divided into the following four categories on the basis of
expected infection risk: 1) limited procedures, including
reduction mammoplasty, mastopexy without implant, and
mastectomy without axillary dissection or reconstruction;
2) procedures that involve implants; 3) mastectomy with
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axillary dissection; and 4) procedures that include recon-
struction. Breast biopsies and local excisions were not
studied. The unit of analysis was procedure, and members
could contribute more than one. However, procedures
were excluded if another qualifying breast surgery
occurred during the preceding or subsequent 60 days. 
We searched claims and pharmacy data during the 60
days after surgery for previously published diagnosis
codes, procedure codes, and antimicrobial agent dispens-
ing suggestive of infection (21). Six categories of “SSI
indicators” included diagnosis codes associated with inpa-
tient, emergency department and outpatient settings, pro-
cedure codes for wound care in any setting, procedure
codes for wound culture in any setting, and antimicrobial
agents. The data available about antimicrobial drugs were
limited to the outpatient setting. We then applied an algo-
rithm that estimated the probability of infection on the
basis of the presence or absence of SSI indicators in the six
categories (21,22). The probability is derived from a logis-
tic regression equation that assigns weights for each of the
SSI indicator types for the individual patient. This proba-
bility could range from 0.006 for procedures with no SSI
indicators to 0.998 for procedures with indicators of all six
types.
Record Review
We reviewed records from all procedures with a pre-
dicted probability of infection >0.03. These constituted
96% of procedures with any SSI indicator. We obtained
records from as many of the following as could be identi-
fied: the surgeon who billed for the initial procedure, the
patient’s primary care provider at the time of surgery, and
full-text electronic ambulatory records (one claims sys-
tem). For procedures with an indicator from a hospital or
emergency department, we also contacted the institution
that submitted the first such claim. From outpatient
providers, we requested all notes during the 60 days after
surgery, and from hospitals and emergency departments,
we requested a discharge summary or progress notes.
Initial requests were mailed, and providers who did not
respond were telephoned 3–6 weeks later. 
Full-text medical records were reviewed in two stages.
A primary reviewer recorded the signs and symptoms dur-
ing the 60 days after surgery that make up the National
Nosocomial Infection Surveillance (NNIS) system defini-
tions for SSI (4). If any signs or symptoms were found, an
infectious disease physician experienced in clinical
research performed a secondary review and classified the
record as follows: 1) no signs or symptoms present, 2)
some signs or symptoms of infection present without meet-
ing the full NNIS definition, or 3) NNIS definition satis-
fied. The secondary reviewer also recorded the depth of
SSI, if evident in the medical record. Discrepancies
between primary and secondary reviews were resolved by
two reviewers. The primary reviewer also determined
whether or not the received records were adequate for
inclusion in further analysis. Outpatient records were con-
sidered adequate if the record had notes for the 6 weeks
after surgery, regardless of whether they contained specif-
ic reference to postoperative care or provided any explana-
tion for the indicator that prompted the review. Hospital
records were considered adequate if they contained notes
from the identified admission or emergency department
visit. 
Completeness of Data
We compared the number of ambulatory claims, diag-
noses associated with these claims, prescriptions before and
after delivery, each SSI indicator type, and SSI confirma-
tion rate among the four claims systems for each 6-month
interval. The overall rate of SSI indicators and the confir-
mation rate for adequate records were not different. Small,
but statistically significant, differences were noted among
claims systems in patient age and the number of diagnoses
on days with ambulatory claims. In one claim system, pro-
cedure codes for wound care were found after 5% of sur-
geries. This indicator type was associated with <1% of
surgeries in the other three claims systems. The rates of pro-
cedure codes for wound culture and inpatient diagnosis
codes were slightly different. A 10% drop over time
occurred in the number of procedures with ambulatory
claims in two systems, but this drop was not associated with
a change in the rate of ambulatory diagnosis SSI indicators.
Analysis
We used the χ2 test to compare categorical values and
the Kruskal-Wallis tests for continuous variables. Analyses
were performed with SAS (SAS, Cary, NC) for Unix ver-
sion 8.2. We extrapolated the full SSI rate by multiplying
the rate of confirmed infection among adequate charts by
the proportion of procedures with a predicted probability
of infection >0.03. We were prepared to compare infection
rates among hospitals, but too few had a sufficiently high
volume. 
Cesarean Section
Automated Data
This study population comprised patients with ICD-9-
CM procedure codes for cesarean section (online
Appendix 1 available from http://www.cdc.gov/ncidod/
eid/vol10no11/04-0784_app1.htm) and was limited to the
three administrative claims systems at Harvard Pilgrim.
Additional exclusion criteria were age <16 years or >50
years and sex recorded as male. Records were searched for
30 days postoperatively rather than 60 days, and the SSIindicator list for cesarean section differed from that for
breast procedures (online Appendix 2 available from
http://www.cdc.gov/ncidod/eid/vol10no11/04-0784_
app2.htm). These codes were chosen to identify SSI,
including endometritis but not mastitis or urinary tract
infection. We ignored SSI indicators associated with proce-
dures having a diagnosis code suggestive of mastitis (mas-
titis indicators) (online Appendix 3 available from http://
www.cdc.gov/ ncidod/eid/vol10no11/04-0784_app3.htm). 
Record Review
We obtained records for procedures with an SSI or mas-
titis indicator, as described for breast procedures. For
cesarean sections we requested records from all of the fol-
lowing that were applicable and available through claims:
any obstetricians who performed the cesarean section, sub-
mitted the first outpatient claim with an SSI indicator, or
was associated with most prenatal visits; the first hospital
or emergency room that generated an SSI indicator; and
full-text electronic ambulatory records (one claims sys-
tem). Of received charts, the greatest portion (44%) came
from the delivering obstetrician.
In addition to identifying SSI, the primary and second-
ary reviewers also assessed the presence of endometritis
and mastitis by using the NNIS definitions (4). Only
events occurring during the first 30 postoperative days
were considered. Reliability between raters was assessed
for the primary review (κ = 0.86 for identification of any
sign or symptom, κ = 0.62 for identifying adequate charts). 
Completeness of Data
We performed the same comparisons among claims
systems for each 6-month period as was done for breast
procedures. Differences occurred in patient age, number of
prescriptions before and after surgery, and days with
ambulatory claims. The differences in SSI indicators were
less pronounced than those noted for breast procedures.
The 10% decrease in ambulatory care claims over time
was found for cesarean sections as well.
Analysis
In addition to the analyses described for breast proce-
dures, we compared SSI rates among institutions with
>150 procedures. We used logistic regression analysis to
compare the proportions of cesarean sections with an SSI
indicator at each hospital, adjusting for age (tertiles), sec-
ular trend (6-month intervals), and claims system. An
interaction term “system*hospital” was tested to deter-
mine whether including data from multiple claims sys-
tems was appropriate when comparing hospitals’ rates of
SSI indicators. 
Results
Breast Surgery
A total of 1,943 breast procedures were eligible (86%
of all procedures identified). Most procedures had associ-
ated postoperative prescribing and ambulatory claims
(Table 1). The most common SSI indicators were antimi-
crobial drug dispensing and ambulatory diagnosis codes;
22% of procedures had at least one indicator. 
We requested records for 395 procedures (96% of those
with an indicator) and received adequate documentation
for 209 (53%) (Table 2). An infection was confirmed
by NNIS criteria for 38 (18%); 28 (13%) had signs or
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criteria. Among the 104 with records that included an
explanation for the SSI indicator, 37% had a confirmed
SSI, and 27% had signs or symptoms. Twenty (53%) con-
firmed infections were superficial; 12 (32%) were deep or
in an organ space, and the depth could not be determined
for 6 infections. Other infections or noninfectious causes
explained the infection indicator for a minority of proce-
dures, but in 50% of cases, neither the indicator nor a like-
ly cause was mentioned. 
Of the 38 infections we identified, 28 (74%) were iden-
tified during the first 30 days, which yielded an extrapo-
lated infection rate based on NNIS (30-day) criteria of
2.8%. SSI indicators were found during a hospital admis-
sion for 40 (2.1%) of the 1,943 procedures, and SSI was
confirmed for 20%, which yielded an inpatient extrapolat-
ed SSI rate of 0.4%. The similarly calculated outpatient
SSI rate was 2.4%. Over the full 60 days reviewed, the
infection rate was 3.8%.
The confirmation rate for patients with SSI indicators
increased with the predicted probability of infection
(Figure 1A), from 13% for those with a predicted proba-
bility <0.1 (76% of procedures with indicators) to 37%
(13/35) for procedures with predicted probabilities of 0.4
to 0.5, and 50% for the 10 procedures with a predicted
probability >0.8. 
Among the four types of breast surgery, the occurrence
of infection indicators ranged from 16% among limited
procedures to 50% among procedures with reconstruction
(Figure 2).The infection indicator type most responsible
for this difference was antimicrobial agents, which were
found after 41% of procedures with reconstruction but
only 9% of limited procedures. The extrapolated 60-day
infection rates among the four surgery types was 2.2% for
limited procedures, 2.5% among procedures with implants,
5.2% among surgeries involving axillary dissection, and
5.5% among surgeries with reconstruction. Not enough
hospitals had >100 procedures to allow comparisons.
Cesarean Section
Atotal of 4,859 (98% of those identified) cesarean sec-
tions were eligible. Antimicrobial drug prescribing was the
most common SSI indicator, and 10% of deliveries had an
indicator of some type (Table 1). One or more requests
could be made for 443 (93%) cesarean sections, and ade-
quate records were received for 255 (58%) (Table 2). SSI
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Figure 1. Infectious outcomes by predicted probability of surgical
site infections (SSI) calculated from SSI indicators for A) breast
procedures and B) cesarean sections. Shown are all procedures
with adequate documentation, which excludes 80%–90% of pro-
cedures with no SSI indicator and predicted probability of infection
at baseline, 0.006. Predicted probability of infection is based on
the categories of SSI indicators found in claims and pharmacy
records. The infectious outcomes for breast procedures are based
on postoperative days 0–60; cesarean section outcomes are from
days 0–30.were confirmed more often than for breast procedures:
82 deliveries (32% of those with adequate records) had a
confirmed SSI, and another 56 (22%) had signs or symp-
toms. Among the 204 with records that included an expla-
nation for the SSI indicator, 40% had a confirmed SSI, and
27% had signs or symptoms. Among confirmed SSI, 45%
were superficial incisional, 6% were deep incisional, 24%
were endometritis, and depth could not be determined for
24%. The extrapolated inpatient infection rate of 0.6% and
the outpatient rate of 2.5% combine for an overall 3.1%
30-day SSI rate.
The distribution of predicted probability of infection
among procedures with SSI indicators differed from
that for breast procedures in having two discrete peaks
(Figure 1B). Among the 73% of adequately documented
procedures with predicted probability <0.4, the SSI confir-
mation rate was 28%. Above predicted probability 0.6 the
confirmation rate was 44% (30/68).
Seven hospitals performed 150 or more cesarean sec-
tions. The proportion of each hospital’s cesarean sections
with an SSI indicator was 7.2%–14.8%, with confirmation
rates that extrapolated to overall SSI rates of 1.6% to 6.7%
(Figure 3). The hospitals’overall rates of confirmed SSI or
signs and symptoms of SSI correlated with their rates of
SSI indicators (p = 0.03). Three hospitals had an SSI indi-
cator rate that was significantly greater than that of the
hospital with the lowest SSI rate (hospital A in Figure 3),
after adjusting for patients’ age, claims system, and 6-
month interval. We found no evidence of significant dif-
ferences between claims systems in ranking hospitals. 
Mastitis indicators were found after 22 deliveries, 15 of
which also had an SSI indicator that would have identified
them as “potential SSI” had they not been specifically
excluded. Among the 14 for which an adequate record was
obtained, 6 (43%) cases met the NNIS criteria for mastitis,
and 5 (36%) had signs or symptoms of mastitis. None had
a confirmed SSI.
Discussion
These findings support the major conclusion of earlier
work with CABG procedures (20): claims data may be a
useful adjunct to conventional surveillance for SSI. The
strength of the claims data for breast procedures and
cesarean delivery was in identifying SSI treated in the
ambulatory setting, with >80% identified solely through
ambulatory claims. In contrast, only 16% of SSI identified
by NNIS occurred in the ambulatory setting (9). We
believe claims data did not identify many of the SSI that
occurred among inpatients because our overall extrapolat-
ed SSI rates were approximately equal to the rates pub-
lished by NNIS during the period of this study. For breast
procedures, the NNIS rate during the decade that included
our study period was 2.1% (23), compared to our extrapo-
lated rate of 2.8%. We note that the NNIS definition of
breast procedure includes four less extensive procedures,
including open biopsy and lumpectomy, that we did not
study (24). For cesarean section, the 3.1% overall SSI rate
identified by claims was almost identical to the 3.2% iden-
tified by NNIS for essentially the same procedures (23,24).
The finding that claims data were apparently more useful
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Figure 2. Infectious outcomes among four categories of breast pro-
cedure. Each bar represents all procedures with predicted proba-
bility of infection  >0.03. Shown are 60-day outcomes extrapolated
from the rates among procedures with adequate records. p, pre-
dicted probability of infection; SSI, surgical site infection; limited,
reduction mammoplasty, mastopexy without implant, and mastec-
tomy without axillary dissection or reconstruction; implant, breast
procedures with an implant; axillary, breast procedures with axillary
dissection; reconstruction, breast procedures with reconstruction.
Figure 3. Hospital-specific infectious outcomes among cesarean
sections with surgical site infection (SSI) indicators. Each bar rep-
resents all deliveries with potential SSI (n = 10–50), with out-
comes extrapolated from those for whom adequate records were
returned. The odds ratio (OR) (95% confidence interval) for a
delivery having an SSI indicator at each hospital, adjusted for
age, claims system, and 6-month interval, is as follows: Hospital
A (reference), hospital B (OR 1.2 [95% CI 0.7–2.1]), hospital C
(OR 1.7 [95% CI 1.0–2.9]), hospital D (OR 1.8 [95% CI 1.1–2.9]),
hospital E (OR 1.7 [95% CI 1.0–2.8], hospital F (OR 1.7 [95% CI
0.9–3.1], hospital G (OR 2.3 [95% CI 1.3–4.0). NNIS, National
Nosocomial Infections Surveillance; CI, confidence interval. for identifying postdischarge SSI than inpatient SSI is a
contrast to our finding in CABG procedures, that claims
data appeared to identify SSI occurring in both inpatient
and outpatient settings. The relative performance of claims
data and routine inpatient surveillance would best be
addressed by comparing results in the same institutions
during comparable periods.
The overall rates at which SSI indicators identified true
SSI were comparable to those we previously described for
CABG procedures (21), if one applies the same criteria,
considering only records that provided some explanation
of the claims-based indicator (proportion with confirmed
SSI or signs and symptoms: 63% for breast surgery, 68%
for cesarean sections, 66% for CABG). The proportions of
breast surgery and cesarean section patients whose records
fully satisfied criteria for SSI were somewhat lower (37%
and 40%) than was the case for our CABG population, for
whom 53% of procedures with any indicator had a con-
firmed SSI (21). We believe these findings represent min-
imum estimates of the predictive value of the SSI
indicators and of the extrapolated infection rates because
many of the medical records we received did not identify
the reason for the claim that yielded the SSI indicator or
because the description of an abnormal surgical site con-
tained too little detail to confirm an infection that may
have been present. For CABG, the lower rates of proce-
dures with signs and symptoms that did not fulfill all SSI
criteria may have been attributable to more thorough doc-
umentation in the ambulatory medical records after CABG
procedures. 
The frequent dispensing of antistaphylococcal antimi-
crobial agents during the month after discharge, especially
after 14% of breast procedures, bears consideration beyond
its effect on lowering the predictive value of this SSI indi-
cator. Much of this dispensing may have been for extended
perioperative prophylaxis, a practice at variance with the
Joint Commission for Accreditation of Healthcare
Organizations’ recent guideline limiting postoperative
antimicrobial prophylaxis to a single day (25). As noted
above, some of these antimicrobial courses may have been
prescribed as treatment for diagnosed bacterial infections
for which the documentation did not satisfy NNIS criteria
or for presumed bacterial infections. Some courses may
have been a prophylaxis regimen that would be considered
inappropriate by current standards. Whatever the reasons,
additional attention to postoperative antimicrobial drug use
will be worthwhile, since if this use continues to be com-
mon, it may represent a large amount of currently undocu-
mented illness or inappropriate antimicrobial drug use. 
The predictive value of SSI indicators after cesarean
section was reduced by the relatively common occurrence
of infections at sites other than the surgical incision. Thus,
these indicators may be useful in detecting postoperative
infectious illness other than SSI. Also, for both breast pro-
cedures and cesarean sections, and in contrast to our expe-
rience with CABG procedures, the patients with an SSI
indicator could be partitioned into groups with higher or
lower likelihood of confirmed SSI. 
We have no direct information about the status of
approximately one quarter of patients with SSI indicators
for whom no medical records could be obtained. Although
we did not collect information systematically about miss-
ing records, most were likely missing for reasons unrelat-
ed to their clinical status, e.g., because the clinicians could
not be contacted, the patients’ records were no longer
available, or because of the refusals of some institutions to
provide records. While these missing patients may have
had higher infection rates than the ones whose records we
were able to review, we observed no important difference
in the extrapolated infection rates between patients in one
of the systems for which we obtained all requested ambu-
latory records because it used an electronic medical record
system. 
These results affirm the ability to combine data from
multiple systems, which may be necessary to obtain
enough information to estimate hospital-specific rates. The
claims data for breast procedures from two health plans
and the three administrative systems within one of those
organizations were comparable in the proportion of proce-
dures with most of the types of SSI indicators and in the
rate at which identified procedures were confirmed to have
an SSI. The higher rate of procedure codes for wound care
in one data system probably represented a difference in
coding practice or data structure. Claims systems do not
need identical SSI indicator rates or confirmation rates for
their data to be pooled, as long as this difference is con-
trolled for when making other comparisons.
Understanding whether a particular claims system is suit-
able for surveillance is important. For instance, if surgeons
are paid a fixed price for a procedure and all postoperative
care, then the claims are unlikely to provide indicators for
ambulatory care. Similarly, antimicrobial indicators are
much less meaningful if patients do not have a drug bene-
fit or if the claims are “carved out,” i.e., paid by another
organization. Finally, for all data systems, routine checks
should be performed for completeness, consistency, and
accuracy of the data. 
These claims-based indicators are not synonymous
with infection and should not be used by themselves to cat-
egorize hospitals or practice groups as having high rates of
complications. Instead, if additional evaluation supports
the usefulness of claims data for this purpose, then these
data might be used to identify a limited number of hospi-
tals that merit additional follow-up to determine whether
their rates of SSI are unusually high. The three hospitals
with higher rates of SSI indicators after cesarean section
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SSI rates, which suggests that focusing resources on
understanding whether any of these three hospitals had
increased rates because of remediable factors may have
been effective. Valid reasons may exist for institutions’
confirmed SSI rates to differ; for instance case-mix might
differ. Additionally, any investigation of a specific hospi-
tal’s indicator rate should begin by determining whether
these elevated rates result from differences in the way
claims for its patients are prepared or processed. 
Widely available claims data, like those used here, may
form the basis of an efficient system for identifying
patients with increased likelihood of having had an SSI
after breast surgery and cesarean section, as has been
reported for CABG. If these results are confirmed, then
assessing claims may be a useful adjunct to other forms of
surveillance and might replace other methods for postdis-
charge surveillance.
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